BioMed Research International / 2017 / Article / Tab 3

Research Article

The Feasibility of Xpert MTB/RIF Testing to Detect Rifampicin Resistance among Childhood Tuberculosis for Prevalence Surveys in Northern China

Table 3

Comparison of costs (USD) on detecting RIF-resistant childhood TB patients from different specimen types.

Specimen types
CSFGLABALFSputumAverage

Gold standard 1 = solid culturePer positive case
Xpert276.00100.23125.30111.28131.86
Per RIF- case
Xpert1932.021202.781628.96890.251371.36

Gold standard 2 = clinical diagnosisPer positive case
Solid culture72.8836.3040.9637.3143.84
Xpert120.7537.0144.0342.3949.33
Per RIF- case
Solid culture992.44783.281009.96573.11828.41
Xpert966.01601.39814.48890.25761.86

RIF-R: rifampicin-resistant.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.